527 related articles for article (PubMed ID: 29547702)
1. Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification.
Jover E; Silvente A; Marín F; Martínez-González J; Orriols M; Martinez CM; Puche CM; Valdés M; Rodriguez C; Hernández-Romero D
FASEB J; 2018 Aug; 32(8):4459-4469. PubMed ID: 29547702
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity.
Varona S; Orriols M; Galán M; Guadall A; Cañes L; Aguiló S; Sirvent M; Martínez-González J; Rodríguez C
Sci Rep; 2018 Sep; 8(1):13258. PubMed ID: 30185869
[TBL] [Abstract][Full Text] [Related]
3. Vascular lysyl oxidase over-expression alters extracellular matrix structure and induces oxidative stress.
Varona S; García-Redondo AB; Martínez-González J; Salaices M; Briones AM; Rodríguez C
Clin Investig Arterioscler; 2017; 29(4):157-165. PubMed ID: 28624291
[TBL] [Abstract][Full Text] [Related]
4. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition.
Nakano-Kurimoto R; Ikeda K; Uraoka M; Nakagawa Y; Yutaka K; Koide M; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1673-84. PubMed ID: 19749165
[TBL] [Abstract][Full Text] [Related]
5. Oligogalacturonic Acid Inhibits Vascular Calcification by Two Mechanisms: Inhibition of Vascular Smooth Muscle Cell Osteogenic Conversion and Interaction With Collagen.
Hodroge A; Trécherel E; Cornu M; Darwiche W; Mansour A; Ait-Mohand K; Verissimo T; Gomila C; Schembri C; Da Nascimento S; Elboutachfaiti R; Boullier A; Lorne E; Courtois J; Petit E; Toumieux S; Kovensky J; Sonnet P; Massy ZA; Kamel S; Rossi C; Ausseil J
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1391-1401. PubMed ID: 28522698
[TBL] [Abstract][Full Text] [Related]
6. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment.
Wen P; Cao H; Fang L; Ye H; Zhou Y; Jiang L; Su W; Xu H; He W; Dai C; Yang J
Exp Cell Res; 2014 Apr; 322(2):302-12. PubMed ID: 24486760
[TBL] [Abstract][Full Text] [Related]
7. Differing calcification processes in cultured vascular smooth muscle cells and osteoblasts.
Patel JJ; Bourne LE; Davies BK; Arnett TR; MacRae VE; Wheeler-Jones CP; Orriss IR
Exp Cell Res; 2019 Jul; 380(1):100-113. PubMed ID: 31004580
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.
Ballester-Servera C; Alonso J; Cañes L; Vázquez-Sufuentes P; Puertas-Umbert L; Fernández-Celis A; Taurón M; Rodríguez-Sinovas A; López-Andrés N; Rodríguez C; Martínez-González J
Biomed Pharmacother; 2023 Nov; 167():115469. PubMed ID: 37729730
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.
Becs G; Zarjou A; Agarwal A; Kovács KÉ; Becs Á; Nyitrai M; Balogh E; Bányai E; Eaton JW; Arosio P; Poli M; Jeney V; Balla J; Balla G
J Cell Mol Med; 2016 Feb; 20(2):217-30. PubMed ID: 26499096
[TBL] [Abstract][Full Text] [Related]
10. Collagen XIV and a related recombinant fragment protect human vascular smooth muscle cells from calcium-/phosphate-induced osteochondrocytic transdifferentiation.
Freise C; Bobb V; Querfeld U
Exp Cell Res; 2017 Sep; 358(2):242-252. PubMed ID: 28655510
[TBL] [Abstract][Full Text] [Related]
11. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.
Martínez-Martínez E; Rodríguez C; Galán M; Miana M; Jurado-López R; Bartolomé MV; Luaces M; Islas F; Martínez-González J; López-Andrés N; Cachofeiro V
J Mol Cell Cardiol; 2016 Mar; 92():96-104. PubMed ID: 26780438
[TBL] [Abstract][Full Text] [Related]
12. Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice.
Marulanda J; Gao C; Roman H; Henderson JE; Murshed M
Bone; 2013 Dec; 57(2):499-508. PubMed ID: 23994172
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
14. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation.
McRobb LS; McGrath KCY; Tsatralis T; Liong EC; Tan JTM; Hughes G; Handelsman DJ; Heather AK
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1127-1137. PubMed ID: 28473445
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.
Alesutan I; Feger M; Tuffaha R; Castor T; Musculus K; Buehling SS; Heine CL; Kuro-O M; Pieske B; Schmidt K; Tomaschitz A; Maerz W; Pilz S; Meinitzer A; Voelkl J; Lang F
Cardiovasc Res; 2016 Jun; 110(3):408-18. PubMed ID: 27001421
[TBL] [Abstract][Full Text] [Related]
16. Wnt16 attenuates TGFβ-induced chondrogenic transformation in vascular smooth muscle.
Beazley KE; Nurminsky D; Lima F; Gandhi C; Nurminskaya MV
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):573-9. PubMed ID: 25614285
[TBL] [Abstract][Full Text] [Related]
17. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells.
Liao XB; Zhang ZY; Yuan K; Liu Y; Feng X; Cui RR; Hu YR; Yuan ZS; Gu L; Li SJ; Mao DA; Lu Q; Zhou XM; de Jesus Perez VA; Yuan LQ
Endocrinology; 2013 Sep; 154(9):3344-52. PubMed ID: 23798596
[TBL] [Abstract][Full Text] [Related]
18. CALU polymorphism A29809G affects calumenin availability involving vascular calcification.
Jover E; Marín F; Quintana M; Pérez-Andreu J; Hurtado JA; Rodríguez C; Martínez-González J; González-Conejero R; Valdés M; Hernández-Romero D
J Mol Cell Cardiol; 2015 May; 82():218-27. PubMed ID: 25823396
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
Galán M; Varona S; Guadall A; Orriols M; Navas M; Aguiló S; de Diego A; Navarro MA; García-Dorado D; Rodríguez-Sinovas A; Martínez-González J; Rodriguez C
FASEB J; 2017 Sep; 31(9):3787-3799. PubMed ID: 28522596
[TBL] [Abstract][Full Text] [Related]
20. Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells.
Alesutan I; Moritz F; Haider T; Shouxuan S; Gollmann-Tepeköylü C; Holfeld J; Pieske B; Lang F; Eckardt KU; Heinzmann SS; Voelkl J
J Mol Med (Berl); 2020 Jul; 98(7):985-997. PubMed ID: 32488546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
